These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32917596)

  • 1. Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosing.
    Zhao H; Brooks SA; Eszterhas S; Heim S; Li L; Xiong YQ; Fang Y; Kirsch JR; Verma D; Bailey-Kellogg C; Griswold KE
    Sci Adv; 2020 Sep; 6(36):. PubMed ID: 32917596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant
    Fang Y; Kirsch JR; Li L; Brooks SA; Heim S; Tan C; Eszterhas S; Cheng HD; Zhao H; Xiong YQ; Griswold KE
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of T cell epitopes in lysostaphin mitigates anti-drug antibody response and enhances antibacterial efficacy in vivo.
    Zhao H; Verma D; Li W; Choi Y; Ndong C; Fiering SN; Bailey-Kellogg C; Griswold KE
    Chem Biol; 2015 May; 22(5):629-39. PubMed ID: 26000749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic-Mediated Affinity Tuning of Lysostaphin Accelerates Bacterial Lysis Kinetics and Enhances
    Zhao H; Eszterhas S; Furlon J; Cheng H; Griswold KE
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant
    Hajiahmadi F; Alikhani MY; Shariatifar H; Arabestani MR; Ahmadvand D
    Int J Nanomedicine; 2019; 14():5943-5955. PubMed ID: 31447553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP; Gemmell CG; Coote PJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysostaphin Lysibody Leads to Effective Opsonization and Killing of Methicillin-Resistant Staphylococcus aureus in a Murine Model.
    Raz A; Serrano A; Thaker M; Alston T; Fischetti VA
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung-Targeting Lysostaphin Microspheres for Methicillin-Resistant
    Lin X; He J; Li W; Qi Y; Hu H; Zhang D; Xu F; Chen X; Zhou M
    ACS Nano; 2021 Oct; 15(10):16625-16641. PubMed ID: 34582183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
    Climo MW; Patron RL; Goldstein BP; Archer GL
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia.
    Chen C; Fan H; Huang Y; Peng F; Fan H; Yuan S; Tong Y
    Biomed Res Int; 2014; 2014():602185. PubMed ID: 25136599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).
    Desbois AP; Lang S; Gemmell CG; Coote PJ
    J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Topical Lysostaphin as a Novel Treatment for Instrumented Rhesus Macaques (
    Cheleuitte-Nieves CE; Diaz LL; Pardos de la Gandara M; Gonzalez A; Freiwald WA; de Lencastre HM; Tomasz A; Euler CW
    Comp Med; 2020 Oct; 70(5):335-347. PubMed ID: 32792040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications of lysostaphin against Staphylococcus aureus.
    Jayakumar J; Kumar VA; Biswas L; Biswas R
    J Appl Microbiol; 2021 Sep; 131(3):1072-1082. PubMed ID: 33382154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
    Placencia FX; Kong L; Weisman LE
    Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models.
    Hertlein T; Sturm V; Lorenz U; Sumathy K; Jakob P; Ohlsen K
    Antimicrob Agents Chemother; 2014; 58(3):1630-8. PubMed ID: 24366730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of activity of recombinant lysostaphin against isolates of meticillin-resistant Staphylococcus aureus from Indian hospitals.
    Kumar A; Khan IA; Sharma PR; K S; Ella KM
    J Med Microbiol; 2014 May; 63(Pt 5):763-766. PubMed ID: 24623634
    [No Abstract]   [Full Text] [Related]  

  • 18. Antistaphylococcal activity of bacteriophage derived chimeric protein P128.
    Vipra AA; Desai SN; Roy P; Patil R; Raj JM; Narasimhaswamy N; Paul VD; Chikkamadaiah R; Sriram B
    BMC Microbiol; 2012 Mar; 12():41. PubMed ID: 22439788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
    Kokai-Kun JF; Chanturiya T; Mond JJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties.
    Cui F; Li G; Huang J; Zhang J; Lu M; Lu W; Huan J; Huang Q
    Drug Deliv; 2011 Apr; 18(3):173-80. PubMed ID: 20726806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.